Neopharmed
Neopharmed Gentili | Per un futuro in salute, insieme.
Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.
About
Neopharmed Gentili is an Italian pharmaceutical company specializing in vascular, cardio-metabolic, and neuropsychiatry therapeutics, expanding internationally.
Summary
Neopharmed is a Biotech company based in Milan, Italy. Its most recent funding was a Series A round in Dec 2018. Investors include Eurazeo.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2024
Sign up to see all 3 events
Funding: Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/neopharmed"><img src="https://indexed.vc/api/badge/company/neopharmed" alt="Neopharmed on Indexed.vc" width="260" height="76" /></a>